Details for Patent: 8,691,860
✉ Email this page to a colleague
Which drugs does patent 8,691,860 protect, and when does it expire?
Patent 8,691,860 protects VIBERZI and is included in one NDA.
This patent has thirty-nine patent family members in twenty-four countries.
Summary for Patent: 8,691,860
| Title: | Crystals and process of making 5-({(2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(-4-phenyl- -1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid |
| Abstract: | The present invention relates to a novel crystals of 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-- 1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid and methods of making the zwitterion of 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-- 1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid. |
| Inventor(s): | Anzalone; Luigi (West Chester, PA), Villani; Frank J. (Perkasie, PA), Teleha; Christopher A. (Fort Washington, PA), Feibush; Penina (Ambler, PA), Fegely; Barry (Quakertown, PA) |
| Assignee: | Furiex Pharmaceuticals, Inc. (Morrisville, NC) |
| Application Number: | 13/987,009 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,691,860 |
|
Patent Claim Types: see list of patent claims | Compound; Use; |
Drugs Protected by US Patent 8,691,860
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie | VIBERZI | eluxadoline | TABLET;ORAL | 206940-001 | May 27, 2015 | RX | Yes | No | ⤷ Subscribe | ⤷ Subscribe | Y | TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) WITH VIBERZI (ELUXADOLINE). | ⤷ Subscribe | |||
| Abbvie | VIBERZI | eluxadoline | TABLET;ORAL | 206940-002 | May 27, 2015 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) WITH VIBERZI (ELUXADOLINE). | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,691,860
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2176234 | ⤷ Subscribe | 122017000010 | Germany | ⤷ Subscribe |
| European Patent Office | 2176234 | ⤷ Subscribe | 132017000028056 | Italy | ⤷ Subscribe |
| European Patent Office | 2176234 | ⤷ Subscribe | 17C1005 | France | ⤷ Subscribe |
| European Patent Office | 2176234 | ⤷ Subscribe | C02176234/01 | Switzerland | ⤷ Subscribe |
| European Patent Office | 2176234 | ⤷ Subscribe | SPC/GB17/019 | United Kingdom | ⤷ Subscribe |
| Australia | 2008275270 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
